New technology enable alternative data types, such as unstructured data, streaming data, and big data. There are challenges and opportunities. Naively applying data science package can result in bias and misleading results which will put a risk to patients. What are the common issues? And where we should focus? This talk will provide our perspective based on recent enterprise initiative on advanced analytics and data science from Eli Lilly and Company